EBIT of Lundbeck 2009-2023
The profit from operations (EBIT) of Danish pharmaceutical company H. Lundbeck fluctuated over the years, and in 2015, the company had their largest operating loss, at approximately 6.8 billion Danish kroner. In 2023, the EBIT stood at around 3.2 billion Danish kroner. H. Lundbeck A/S is a Danish pharmaceutical company founded in 1915 with its headquarter in Copenhagen. The key products produced by the company are pharmaceuticals for the nervous system.